Copyright Reports & Markets. All rights reserved.

Global Interchangeable Biosimilars Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Interchangeable Biosimilars Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Crohn’s Disease
    • 1.3.3 Ulcerative Colitis
    • 1.3.4 Psoriasis
    • 1.3.5 Diabetes
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Interchangeable Biosimilars Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Pharmacy
    • 1.4.4 Others
  • 1.5 Global Interchangeable Biosimilars Market Size & Forecast
    • 1.5.1 Global Interchangeable Biosimilars Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Interchangeable Biosimilars Sales Quantity (2019-2030)
    • 1.5.3 Global Interchangeable Biosimilars Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Biocon
    • 2.1.1 Biocon Details
    • 2.1.2 Biocon Major Business
    • 2.1.3 Biocon Interchangeable Biosimilars Product and Services
    • 2.1.4 Biocon Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Biocon Recent Developments/Updates
  • 2.2 Viatris
    • 2.2.1 Viatris Details
    • 2.2.2 Viatris Major Business
    • 2.2.3 Viatris Interchangeable Biosimilars Product and Services
    • 2.2.4 Viatris Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Viatris Recent Developments/Updates
  • 2.3 Amgen
    • 2.3.1 Amgen Details
    • 2.3.2 Amgen Major Business
    • 2.3.3 Amgen Interchangeable Biosimilars Product and Services
    • 2.3.4 Amgen Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Amgen Recent Developments/Updates
  • 2.4 Coherus BioSciences
    • 2.4.1 Coherus BioSciences Details
    • 2.4.2 Coherus BioSciences Major Business
    • 2.4.3 Coherus BioSciences Interchangeable Biosimilars Product and Services
    • 2.4.4 Coherus BioSciences Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Coherus BioSciences Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Interchangeable Biosimilars Product and Services
    • 2.5.4 Pfizer Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 Sandoz International
    • 2.6.1 Sandoz International Details
    • 2.6.2 Sandoz International Major Business
    • 2.6.3 Sandoz International Interchangeable Biosimilars Product and Services
    • 2.6.4 Sandoz International Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sandoz International Recent Developments/Updates
  • 2.7 Merck & Co.
    • 2.7.1 Merck & Co. Details
    • 2.7.2 Merck & Co. Major Business
    • 2.7.3 Merck & Co. Interchangeable Biosimilars Product and Services
    • 2.7.4 Merck & Co. Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Merck & Co. Recent Developments/Updates
  • 2.8 Boehringer Ingelheim
    • 2.8.1 Boehringer Ingelheim Details
    • 2.8.2 Boehringer Ingelheim Major Business
    • 2.8.3 Boehringer Ingelheim Interchangeable Biosimilars Product and Services
    • 2.8.4 Boehringer Ingelheim Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.9 Samsung Bioepis
    • 2.9.1 Samsung Bioepis Details
    • 2.9.2 Samsung Bioepis Major Business
    • 2.9.3 Samsung Bioepis Interchangeable Biosimilars Product and Services
    • 2.9.4 Samsung Bioepis Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Samsung Bioepis Recent Developments/Updates
  • 2.10 Teva Pharmaceutical
    • 2.10.1 Teva Pharmaceutical Details
    • 2.10.2 Teva Pharmaceutical Major Business
    • 2.10.3 Teva Pharmaceutical Interchangeable Biosimilars Product and Services
    • 2.10.4 Teva Pharmaceutical Interchangeable Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Teva Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Interchangeable Biosimilars by Manufacturer

  • 3.1 Global Interchangeable Biosimilars Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Interchangeable Biosimilars Revenue by Manufacturer (2019-2024)
  • 3.3 Global Interchangeable Biosimilars Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Interchangeable Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Interchangeable Biosimilars Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Interchangeable Biosimilars Manufacturer Market Share in 2023
  • 3.5 Interchangeable Biosimilars Market: Overall Company Footprint Analysis
    • 3.5.1 Interchangeable Biosimilars Market: Region Footprint
    • 3.5.2 Interchangeable Biosimilars Market: Company Product Type Footprint
    • 3.5.3 Interchangeable Biosimilars Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Interchangeable Biosimilars Market Size by Region
    • 4.1.1 Global Interchangeable Biosimilars Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Interchangeable Biosimilars Consumption Value by Region (2019-2030)
    • 4.1.3 Global Interchangeable Biosimilars Average Price by Region (2019-2030)
  • 4.2 North America Interchangeable Biosimilars Consumption Value (2019-2030)
  • 4.3 Europe Interchangeable Biosimilars Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Interchangeable Biosimilars Consumption Value (2019-2030)
  • 4.5 South America Interchangeable Biosimilars Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Interchangeable Biosimilars Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Interchangeable Biosimilars Sales Quantity by Type (2019-2030)
  • 5.2 Global Interchangeable Biosimilars Consumption Value by Type (2019-2030)
  • 5.3 Global Interchangeable Biosimilars Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Interchangeable Biosimilars Sales Quantity by Application (2019-2030)
  • 6.2 Global Interchangeable Biosimilars Consumption Value by Application (2019-2030)
  • 6.3 Global Interchangeable Biosimilars Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Interchangeable Biosimilars Sales Quantity by Type (2019-2030)
  • 7.2 North America Interchangeable Biosimilars Sales Quantity by Application (2019-2030)
  • 7.3 North America Interchangeable Biosimilars Market Size by Country
    • 7.3.1 North America Interchangeable Biosimilars Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Interchangeable Biosimilars Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Interchangeable Biosimilars Sales Quantity by Type (2019-2030)
  • 8.2 Europe Interchangeable Biosimilars Sales Quantity by Application (2019-2030)
  • 8.3 Europe Interchangeable Biosimilars Market Size by Country
    • 8.3.1 Europe Interchangeable Biosimilars Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Interchangeable Biosimilars Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Interchangeable Biosimilars Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Interchangeable Biosimilars Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Interchangeable Biosimilars Market Size by Region
    • 9.3.1 Asia-Pacific Interchangeable Biosimilars Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Interchangeable Biosimilars Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Interchangeable Biosimilars Sales Quantity by Type (2019-2030)
  • 10.2 South America Interchangeable Biosimilars Sales Quantity by Application (2019-2030)
  • 10.3 South America Interchangeable Biosimilars Market Size by Country
    • 10.3.1 South America Interchangeable Biosimilars Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Interchangeable Biosimilars Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Interchangeable Biosimilars Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Interchangeable Biosimilars Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Interchangeable Biosimilars Market Size by Country
    • 11.3.1 Middle East & Africa Interchangeable Biosimilars Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Interchangeable Biosimilars Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Interchangeable Biosimilars Market Drivers
  • 12.2 Interchangeable Biosimilars Market Restraints
  • 12.3 Interchangeable Biosimilars Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Interchangeable Biosimilars and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Interchangeable Biosimilars
  • 13.3 Interchangeable Biosimilars Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Interchangeable Biosimilars Typical Distributors
  • 14.3 Interchangeable Biosimilars Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    An interchangeable biosimilar is a biopharmaceutical product that is similar to an approved reference biologic and has demonstrated equivalence in terms of quality, efficacy and safety. Interchangeable biosimilars may have minor differences in composition, quality, purity and biological activity compared to the reference biological drug, but these differences do not affect their efficacy or safety. Interchangeable biosimilars are generally considered to be effective alternatives to reference biologics and can be used interchangeably in clinical practice. These generics are often cheaper, thus providing patients with more therapeutic options.

    According to our (Global Info Research) latest study, the global Interchangeable Biosimilars market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Interchangeable Biosimilars market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Interchangeable Biosimilars market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Interchangeable Biosimilars market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Interchangeable Biosimilars market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Interchangeable Biosimilars market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Interchangeable Biosimilars
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Interchangeable Biosimilars market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocon, Viatris, Amgen, Coherus BioSciences, Pfizer, Sandoz International, Merck & Co., Boehringer Ingelheim, Samsung Bioepis, Teva Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Interchangeable Biosimilars market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Crohn’s Disease
    Ulcerative Colitis
    Psoriasis
    Diabetes
    Other
    Market segment by Application
    Hospitals
    Pharmacy
    Others
    Major players covered
    Biocon
    Viatris
    Amgen
    Coherus BioSciences
    Pfizer
    Sandoz International
    Merck & Co.
    Boehringer Ingelheim
    Samsung Bioepis
    Teva Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Interchangeable Biosimilars product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Interchangeable Biosimilars, with price, sales quantity, revenue, and global market share of Interchangeable Biosimilars from 2019 to 2024.
    Chapter 3, the Interchangeable Biosimilars competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Interchangeable Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Interchangeable Biosimilars market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Interchangeable Biosimilars.
    Chapter 14 and 15, to describe Interchangeable Biosimilars sales channel, distributors, customers, research findings and conclusion.

    Buy now